Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03FEV
|
||||
Former ID |
DNC006435
|
||||
Drug Name |
N-methyl-2-(pyridin-3-yloxy)ethanamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527965] | ||
Structure |
Download2D MOL |
||||
Formula |
C8H12N2O
|
||||
Canonical SMILES |
CNCCOC1=CN=CC=C1
|
||||
InChI |
1S/C8H12N2O/c1-9-5-6-11-8-3-2-4-10-7-8/h2-4,7,9H,5-6H2,1H3
|
||||
InChIKey |
HKLZABNBARUZMN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Neuronal acetylcholine receptor protein, beta-2 chain | Target Info | Inhibitor | [527965] | |
Neuronal acetylcholine receptor protein, alpha-4 chain | Target Info | Inhibitor | [527965] | ||
Reactome | Highly sodium permeable acetylcholine nicotinic receptors | ||||
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | |||||
Highly calcium permeable nicotinic acetylcholine receptorsR-HSA-629587:Highly sodium permeable acetylcholine nicotinic receptors | |||||
Highly calcium permeable nicotinic acetylcholine receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.